mRNA cancer therapeutics specialist CureVac AG has baged US$50m upfront and is eglible to receive up to...
Up To Date
Latest News
Belgian Nanobody® producer Ablynx NV said it aims to raise US$175m of its ordinary shares in a global...
A complaint against the EMA’s handling of a referral procedure relating to potential side effects of...
The European Medicines Agency (EMA) has upgraded Roche’s Alecensa (Alectinib) from second-line to first-line...
German infection specialist InflaRx (Jena) raised US$55m in a Series D financing co-led by Bain Capital Life...
Norwegian Targovax ASA (Oslo) has reported tremendous safety, immunogenicity, and one-year survival data, of...